Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Colonic Neoplasms × Tinzaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 7 Venous Thrombosis 4 Neoplasms 4 Pulmonary Embolism 3 Thromboembolism 2 Lung Neoplasms 2 Thrombosis 1 Thrombocytopenia 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Kidney Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Fluorouracil 188 Leucovorin 173 Oxaliplatin 168 Irinotecan 130 Bevacizumab 92 Capecitabine 76 Cetuximab 73 Folfox protocol 48 Chemotherapy, Adjuvant 29 Panitumumab 25 pembrolizumab 22 Colonoscopy 19 Floxuridine 18 Nivolumab 17 IFL protocol 16 Radiotherapy 15 Gemcitabine 15 Drug Therapy 15 Early Intervention, Educational 14 Celecoxib 14 Neoadjuvant Therapy 13 Laparoscopy 13 Cyclophosphamide 13 XELOX 12 Exercise 12 Erlotinib Hydrochloride 12 Counseling 12 Aspirin 12 trifluridine tipiracil drug combination 11 Magnetic Resonance Spectroscopy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01455831 2021-05-17

PERIOP-01

Ottawa Hospital Research Institute

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡